Cartesian Therapeutics, Inc. (RNAC)
7.38
-0.89
(-10.76%)
USD |
NASDAQ |
May 15, 16:00
7.375
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics Market Cap : 216.84M for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 23.66B |
| Regeneron Pharmaceuticals, Inc. | 73.20B |
| Precision BioSciences, Inc. | 187.61M |
| ACADIA Pharmaceuticals, Inc. | 3.664B |
| Alnylam Pharmaceuticals, Inc. | 38.32B |
Market Cap Related Metrics
| PS Ratio | 109.47 |
| Price | 7.38 |
| Earnings Yield | -78.56% |